Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 21, 2024 08:00 ET
|
Upstream Bio
Upstream Bio CEO to participate in fireside chat at Piper Sandler
Upstream Bio to Present Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society (ATS) International Conference
May 15, 2024 07:00 ET
|
Upstream Bio, Inc.
Upstream Bio will present clinical data from dose-ranging study of verekitug (UPB-101) in adults with asthma at the American Thoracic Society conference